Skip to main content

Table 2 Mean availability of individual SRHC across sectors, by country

From: Access to sexual and reproductive health commodities in East and Southern Africa: a cross-country comparison of availability, affordability and stock-outs in Kenya, Tanzania, Uganda and Zambia

Commodities

Mean Availability (%)

Kenya

Tanzania

Uganda

Zambia

Public

Private

PNFP

Public

Private

PNFP

Public

Private

PNFP

Public

Private

PNFP

Family Planning

 Oral contraceptivea

91

80

72

69

47

40

75

36

43

91

67

83

 Levonorgestrel 750 mcg

47

71

32

8

0

0

35

30

24

41

61

41

 Injectable contraceptiveb

92

32

66

82

59

53

62

51

67

72

30

79

 Male condoms

84

85

79

82

52

47

93

72

81

89

89

86

 Female condoms

56

13

39

33

22

27

18

17

33

60

5

48

 Intrauterine contraceptive devicen

82

29

48

62

65

53

72

39

56

51

2

41

 Implantc,n

87

30

79

84

78

73

89

64

67

71

0

62

 Diaphragm

0

0

4

0

0

0

0

0

0

0

0

0

Maternal Health

 Oxytocin injectionn,p

87

41

67

75

42

56

80

50

64

94

50

78

 Misoprostol

33

34

35

49

35

22

82

48

56

11

27

26

 Methyldopak,m,n

77

77

83

76

73

73

24

14

36

12

51

17

 Magnesium sulphated,n,p

59

10

44

70

18

48

69

10

42

13

0

12

 Calcium gluconatek,m,n,q

71

29

71

44

0

44

43

8

27

67

0

0

 Ferrous salt

57

50

43

5

3

4

4

27

37

75

55

71

 Folic acid

55

77

79

63

50

48

64

71

63

80

82

79

 Ferrous Salt: Folic Acid Tabletg

62

8

48

20

5

14

27

10

33

1

7

2

Antibiotics and Antifungals

 Metronidazole

68

80

87

61

92

86

75

94

84

88

87

93

 Clotrimazolee

70

74

83

39

47

38

67

63

67

24

45

17

 Gentamicinn

58

39

61

43

45

40

30

67

67

48

33

50

 Procaine benzylpenicillin

NS

NS

NS

26

33

36

33

48

44

2

34

7

 Benzathine benzylpenicillinn

39

16

30

80

60

70

70

72

67

60

69

74

 Benzylpenicillin

46

34

50

NS

NS

NS

NS

NS

NS

82

34

86

 Amoxicillinf

62

38

43

74

30

42

40

40

49

77

88

81

Newborn- and Child Health

 Dexamethasonek,o,q

81

82

63

10

27

32

76

50

46

67

50

0

 Zinc ORS co-pack

68

28

41

29

3

4

44

6

26

13

5

17

 Zinch

86

82

93

36

75

74

44

70

67

53

46

60

 ORS sachetsi

77

73

83

75

72

82

53

70

63

32

57

48

 Chlorhexidine 4%

38

9

30

7

3

6

26

6

19

6

3

10

SRH medical devices

 Vasectomy kitk,l,n

19

6

8

3

5

0

17

8

15

7

4

14

 Tubal ligation kitk,l,n

23

35

13

13

9

5

17

11

24

10

1

10

 Manual vacuum aspiration kitj,n

66

59

56

38

38

26

48

36

48

54

38

64

 Speculumj,o

86

78

84

84

67

66

88

75

92

84

38

94

 Cervical dilatorj,n

34

41

49

12

17

14

46

31

58

28

25

25

 Incubator

68

47

79

11

13

16

16

4

14

27

13

53

 Monitork,n

39

53

63

11

15

16

22

11

33

14

13

17

 Ultrasound scank,o

45

53

63

13

45

36

52

63

92

19

50

22

 Ventilatork,n

32

41

42

5

5

6

9

8

3

9

25

17

 Foetal scopej,n

82

78

88

97

80

92

94

92

91

86

63

78

 Resuscitator (adult size)j,n

45

33

49

31

22

18

33

44

45

28

25

39

 Resuscitator (infant size)j,n

63

44

53

63

38

46

65

56

70

50

38

72

 Bag and mask (size 0)j,o

58

52

77

59

37

46

68

25

62

52

38

75

 Suction devicej

68

67

79

71

52

62

65

54

81

75

50

81

 Training mannequin (infant)j,n

20

15

23

36

22

32

26

6

27

26

0

33

  1. NS not surveyed
  2. a‘Oral contraceptive’ combines availability of ethinylestradiol + levonorgestrel (multiple formulations) and/or ethinylestradiol + norethisterone (multiple formulations) and/or ethinylestradiol + desorgestrel (multiple formulations) and/or levonorgestrel 30mcg at the facility
  3. b‘Injectable contraceptive’ combines availability of medroxyprogesterone acetate (150 mg in 1 ml vial or 104 mg in 1 ml vial) and/or norethisterone enanthate 200 mg/ml in 1 ml vial and/or estradiol cypionate + medroxyprogesterone acetate (5 mg + 25 mg) at the facility
  4. c‘Implant’ combines availability of levonorgestrel implant and/or etonogestrel implant at the facility
  5. d‘Magnesium sulphate’ combines availability of magnesium sulphate 500 mg in 1 ml and/or magnesium sulphate 500 mg in 2 ml and/or magnesium sulphate 500 mg in 10 ml at the facility
  6. e‘Clotrimazole’ combines availability of clotrimazole cream (1%, 15 g tube) and/or clotrimazole pessary (100 mg, 200 mg or 500 mg)
  7. f‘Amoxicillin’ combines availability of amoxicillin 125 mg and/or amoxicillin 250 mg at the facility
  8. g‘Ferrous salt: folic acid tablets’ combines availability of the ferrous salt: folic acid (60 mg + 400mcg) and/or ferrous salt: folic acid (150 mg + 500mcg) and/or ferrous salt: folic acid (200 mg + 500mcg) at the facility
  9. h‘Zinc’ combines availability of zinc 10 mg in 5 ml syrup and/or zinc 20 mg and/or zinc ORS co-pack at the facility
  10. i‘ORS sachets’ combines availability of ORS sachets of 200 ml and/or 500 ml and/or 1 L and/or zinc ORS co-pack at the facility
  11. jAvailable from health centre and up in Kenya
  12. kAvailable from primary/county hospital and up in Kenya
  13. lAvailable from health centre and up in Tanzania
  14. mAvailable from council hospital and up in Tanzania
  15. nAvailable from health centre III and up in Uganda
  16. oAvailable from health centre IV and up in Uganda
  17. pAvailable from general hospital and up in Zambia
  18. qAvailable from central hospital and up in Zambia